Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Hospital utilization patterns and costs for adult sickle cell patients in Illinois.
1997
Silent Cerebral Infarcts in Sickle Cell Anemia: A Risk Factor Analysis
1999
Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine?
2001
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Predicting the impacts of epidemic outbreaks on global supply chains: A simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case
2020 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Pain in Sickle Cell Disease
1991
Common roots: a contextual review of HIV epidemics in black men who have sex with men across the African diaspora
2012
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
2013
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Prediction of Adverse Outcomes in Children with Sickle Cell Disease
2000
A comparison of the use of transoesophageal Doppler and thermodilution techniques for cardiac output determination
1996
Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study
2004
Effect of GB virus C viremia on HIV acquisition and HIV set-point
2005 StandoutNobel
Blood bank management of sickle cell patients at comprehensive sickle cell centers
2007
Outpatient Therapy with Ceftriaxone and Oral Cefixime for Selected Febrile Children with Sickle Cell Disease
1996
Genital Infection of Female Chimpanzees with Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Successes and challenges of HIV prevention in men who have sex with men
2012
Long-term management of splenic sequestration in children with sickle cell disease
1990
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
2015
Training is required to improve the reliability of esophageal doppler to measure cardiac output in critically ill patients
1998
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Activity‐based costs of blood transfusions in surgical patients at four hospitals
2009 Standout
Early Human Immunodeficiency Virus (HIV) Infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: Risk Behaviors, Symptoms, and Early Plasma and Genital Tract Virus Load
2001
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control
2000
Causes of death in sickle cell disease: an autopsy study
2003
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
2009
Asthma is associated with Increased mortality in individuals with sickle cell anemia
2007
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
2014
PROSPECTS FOR A HEPATITIS C VIRUS VACCINE
1999 StandoutNobel
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Outcome of Sickle Cell Anemia
2005
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
On the relationship between mean antibody level, seroprotection and clinical protection from influenza
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis
2012 Standout
Sickle-cell disease
2010 Standout
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Consensus Review of Optimal Perioperative Care in Colorectal Surgery
2009 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death
1994 Standout
Guidelines for the management of the acute painful crisis in sickle cell disease
2003
Global epidemiology of haemoglobin disorders and derived service indicators
2008 Standout
Sickle cell disease in Africa: burden and research priorities
2007
Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials
2003
The paradox of hemoglobin SC disease
2003
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Incidence of Invasive Pneumococcal Disease among Individuals with Sickle Cell Disease before and after the Introduction of the Pneumococcal Conjugate Vaccine
2007
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)
2002
Large Sample Randomization Inference of Causal Effects in the Presence of Interference
2013
Principles and problems of transfusion in sickle cell disease
2001
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
How I treat acute chest syndrome in children with sickle cell disease
2011
Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on ‘Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines’, 31 January–2 February 2006, IAVI, New York, USA
2007
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy
2002
High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program
2015
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
1997
Nutritional Supplementation Increases Rifampin Exposure among Tuberculosis Patients Coinfected with HIV
2014
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
1998 Standout
A case for developing North-South partnerships for research in sickle cell disease
2004
Malaria chemoprophylaxis in sickle cell disease
2006
Statistical Studies of Infectious Disease Incidence
1999
Financial analysis of chronic transfusion for stroke prevention in sickle cell disease
2000
Exactp-Values for Network Interference
2016 StandoutNobel
Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease
1999
Population Biology, Evolution, and Infectious Disease: Convergence and Synthesis
1999 Science
Guidelines for the Primary Prevention of Stroke
2014 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Pain, quality of life, and coping in sickle cell disease.
1996
A comparison of the use of transoesophageal Doppler and thermodilution techniques for cardiac output determination
1996
Survival of children with sickle cell disease
2004
A Game-Theoretic Model of International Influenza Vaccination Coordination
2013
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
2006 Standout
Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease
1999
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi
2015
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases
2000
Sensitivity Analysis in Observational Research: Introducing the E-Value
2017 Standout
Insecticide-treated bed nets and curtains for preventing malaria
2004 Standout
Factors associated with survival in a contemporary adult sickle cell disease cohort
2014
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion
2012 StandoutNobel
Transfusion management of sickle cell disease
1993
A Meta-Analysis of Studies Using Bias and Precision Statistics to Compare Cardiac Output Measurement Techniques
1999 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil
2013
Goal-directed Intraoperative Fluid Administration Reduces Length of Hospital Stay after Major Surgery
2002 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Impact of long‐term erythrocytapheresis on growth and peak height velocity of children with sickle cell disease
2014
Protein C and Protein S Activity in Sickle Cell Disease and Stroke
1997
Drug Resistance in Leishmaniasis
2006 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
1995
Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics*
2001
Works of Wasima Rida being referenced
AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?
2010
Some statistical issues in HIV vaccine trials
1994
Intermediate-Size Trials for the Evaluation of HIV Vaccine Candidates: A Workshop Summary
1997
Identifying At-Risk Populations in Kenya and South Africa
2012
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations
1998
Mortality in Children and Adolescents With Sickle Cell Disease
1989
Asymptotic Properties of Some Estimators for the Infection Rate in the General Stochastic Epidemic Model
1991
Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease.
1989
Continuous noninvasive monitoring of cardiac output with esophageal Doppler ultrasound during cardiac surgery.
1986
Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
2012
HIV vaccine trials: some design issues including sample size calculation.
1993
Continuous Noninvasive Monitoring of Cardiac Output with Esophageal Doppler Ultrasound during Cardiac Surgery
1986
Lot Consistency as an Equivalence Problem
2004